Historique
Périodique
Improvement in measures of psychological distress amongst amphetamine misusers treated with brief cognitive-behavioural therapy (CBT)
(Amélioration de l'évaluation de la détresse psychologique ressentie par des personnes abusant d'amphétamines en cours de thérapie cognitivo-comportementale brève)
Auteur(s) :
FEENEY, G. F. X. ;
CONNOR, J. P. ;
YOUNG, R. M. D. ;
TUCKER, J. ;
MAC PHERSON A.
Année
2006
Page(s) :
1833-1843
Langue(s) :
Anglais
Refs biblio. :
26
Domaine :
Drogues illicites / Illicit drugs
Note générale :
Addictive Behaviors, 2006, 31, (10), 1833-1843
Note de contenu :
graph. ; tabl.
Résumé :
ENGLISH :
This trial of cognitivebehavioural therapy (CBT) based amphetamine abstinence program (n = 507) focused on refusal self-efficacy, improved coping, improved problem solving and planning for relapse prevention. Measures included the Severity of Dependence Scale (SDS), the General Health Questionnaire-28 (GHQ-28) and Amphetamine Refusal Self-Efficacy. Psychiatric case identification (caseness) across the four GHQ-28 sub-scales was compared with Australian normative data. Almost 90% were amphetamine-dependent (SDS 8.15 + 3.17). Pre-treatment, all GHQ-28 sub-scale measures were below reported Australian population values. Caseness was substantially higher than Australian normative values {Somatic Symptoms (52.3%), Anxiety (68%), Social Dysfunction (46.5%) and Depression (33.7%)}. One hundred and sixty-eight subjects (33%) completed and reported program abstinence. Program completers reported improvement across all GHQ-28 sub-scales {Somatic Symptoms (p < 0.001), Anxiety (p < 0.001), Social Dysfunction (p < 0.001) and Depression (p < 0.001)}. They also reported improvement in amphetamine refusal self-efficacy (p < 0.001). Improvement remained significant following intention-to-treat analyses, imputing baseline data for subjects that withdrew from the program. The GHQ-28 sub-scales, Amphetamine Refusal Self-Efficacy Questionnaire and the SDS successfully predicted treatment compliance through a discriminant analysis function (p < .001). (Editor's abstract.)
Affiliation :
Alcohol and Drug Assessment Unit, Princess Alexandra Hospital, Brisbane, Queensland 4102. E-mail Gerald_Feeneyhealth.qld.gov.au
Australie. Australia.
Australie. Australia.